# Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock

> **NCT00148278** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Versailles** · enrollment: 330 (actual)

## Conditions studied

- Septic Shock
- Severe Sepsis
- Infections

## Interventions

- **DRUG:** norepinephrine and dobutamine
- **DRUG:** epinephrine plus placebo of dobutamine

## Key facts

- **NCT ID:** NCT00148278
- **Lead sponsor:** University of Versailles
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2004-12
- **Final completion:** 2005-12
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2010-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148278, "Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00148278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*